Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-17 Option Award | 2026-06-22 4:32 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,275 | $0 | 20,275 (Indirect) | View |
| 2026-06-17 Option Award | 2026-06-22 4:14 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:13 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:10 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:09 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:08 pm | N/A 2036-06-16 | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2026-05-21 Tax Withholding | 2026-05-26 4:09 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 13,729 | $1.79 | 2,631,660 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 9,366 | $0 | 12,238,762 (Indirect) | View |
| 2026-05-18 Option Award | 2026-05-20 4:36 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:36 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:35 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:35 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 9,366 | $0 | 9,366 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 14,227 | $0 | 18,134 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 38,817 | $0 | 38,817 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 49,830 | $0 | 82,767 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 46,167 | $0 | 67,150 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 38,584 | $0 | 52,992 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 72,981 | $0 | 146,953 (Direct) | View |
| 2026-05-18 Option Award | 2026-05-20 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 252,801 | $0 | 2,645,389 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.92 | 3,907 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $1.92 | 32,937 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 404 | $1.92 | 14,408 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $1.92 | 73,972 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 1,743 | $1.92 | 2,392,588 (Direct) | View |
| 2026-04-22 Option Award | 2026-04-23 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,888,888 | $1.8 | 12,229,396 (Indirect) | View |
| 2026-04-17 Tax Withholding | 2026-04-21 5:05 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.78 | 33,121 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:22 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:21 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 174,068 | $0 | 174,068 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:19 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 129,760 | $0 | 129,760 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:19 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 132,925 | $0 | 132,925 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:17 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 94,946 | $0 | 94,946 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:16 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 186,728 | $0 | 186,728 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:15 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 602,705 | $0 | 602,705 (Direct) | View |
| 2026-02-21 Tax Withholding | 2026-02-24 4:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 14,265 | $1.53 | 2,394,331 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 116 | $1.63 | 4,006 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:12 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 217 | $1.63 | 33,679 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 471 | $1.63 | 14,812 (Direct) | View |